ENTITY
Dr. Reddy's Laboratories

Dr. Reddy's Laboratories (DRRD IN)

161
Analysis
Health CareIndia
Dr. Reddy's Laboratories Limited provides a complete range of pharmaceutical services. The Company manufactures bulk drugs and formulations including verapamil and cephalexin. The Company also manufactures and exports molecules such as norfloxacin, ciprofloxacin, and varieties of semi-synthetic penicillin. The Company markets its products in India and around the world.
more
29 Feb 2020 19:07

COVID-19 : A Viral Threat to Pharma Supply Chain

Corona Virus shadows are glooming all over the world, and these fears have just begun. As a major highlight of 2020, the virus has conquered the...

Logo
418 Views
Share
29 Jan 2020 07:51

EM Pullback Opportunity

Supporting our global bull market thesis, uptrends remain intact for the major global indexes (MSCI ACWI, ACWI ex-US, EAFE, and EM). At this point,...

Logo
416 Views
Share
18 Jun 2019 14:39

Shikha Sharma Rewarded with Prominent Directorships for Mismanagement at Axis Bank

On June 14, 2019, Tech Mahindra (TECHM IN)  joined the ranks of Tata Global Beverages, Ambuja Cements (ACEM IN)  and Dr. Reddy'S Laboratories (DRRD...

Logo
598 Views
Share
08 Mar 2019 11:33

India Generic Drugs: "Antitrust Unredacted"

New information in the government's investigation into antitrust violations by generic drug companies continues to surface. An unredacted version...

Share
01 Jan 2019 22:29

India Generic Drugs: Antitrust Suit Could Cost Billions

This Insight builds on our previous Insight, India Generic Drugs: US Antitrust Inquiry Widens by discussing estimated potential liabilities and...

Share
x